SCHEMBL6693716

SCHEMBL6693716

NC(=O)c1cccc2c1c1c(O)cccc1n2Cc1cccc(C(F)(F)F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 4/20 0.48
MAPT P10636 1/20 0.48
MAPK10 P53779 1/20 0.48
F2 P00734 3/20 0.46
ATM Q13315 2/20 0.46
MAPK8 P45983 1/20 0.46
ICMT O60725 1/20 0.45
PARP1 P09874 1/20 0.44
FABP4 P15090 2/20 0.44
PPARG P37231 2/20 0.44
FEN1 P39748 1/20 0.44
PLA2G2A P14555 1/20 0.43
PLA2G1B P04054 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ATG4B Q9Y4P1 1/20 0.43
AURKA O14965 1/20 0.43
RPS6KB1 P23443 1/20 0.43
AURKB Q96GD4 1/20 0.43
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6781985 0.90 MAPT (0.44) F10MAPTMAPK10F2ATM
SCHEMBL6776332 0.89 MAPT (0.43) F10MAPTMAPK10ATMMAPK8
SCHEMBL6776400 0.89 MAPT (0.45) F10MAPTMAPK10ATMMAPK8
SCHEMBL6776586 0.87 MAPT (0.42) F10MAPTMAPK10ATMMAPK8
SCHEMBL6775381 0.86 PPARG (0.44) F10MAPTMAPK10ATMMAPK8
SCHEMBL6693179 0.86 PPARG (0.48) F10MAPTMAPK10F2ATM
SCHEMBL6691129 0.85 F10 (0.46) F10F2MAPK8PARP1FABP4
SCHEMBL6781743 0.85 TRPV1 (0.45) F10MAPTMAPK10ATMMAPK8
SCHEMBL2589197 0.84 PPARG (0.44) F10MAPTMAPK10ATMMAPK8
SCHEMBL6691736 0.84 FEN1 (0.46) PPARGFEN1PLA2G2APLA2G1BL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0950657-B1 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitors LILLY CO ELI (US) 2004-07-14 EP disclosed
EP-0952149-B1 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors LILLY CO ELI (US) 2004-06-09 EP disclosed
US-6713645-B1 INHIBITING SPLA2 MEDIATED RELEASE OF FATTY ACIDS FOR TREATMENT OF CONDITIONS SUCH AS SEPTIC SHOCK ELI LILLY AND COMPANY 2004-03-30 US disclosed
US-6177440-B1 THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR ELI LILLY AND COMPANY 2001-01-23 US disclosed
EP-0952149-A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors ELI LILLY AND COMPANY (US) 1999-10-27 EP disclosed
EP-0950657-A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitors ELI LILLY AND COMPANY (US) 1999-10-20 EP disclosed